Three Tickers Nobody's Talking About That Could Be the Next Big Trade

The financial internet is collectively losing its mind over SPCX options and oil price swings. Fine. But while the crowd chases the shiny objects, BullApe went digging for the names that don't trend — yet. Here are three small-cap picks with niche moats, upcoming catalysts, and the kind of under-the-radar profile that makes for genuinely asymmetric setups.

$IRTC (iRhythm Technologies) — Shoutout to the Goldman Sachs Healthcare Conference coverage surfacing on Bloomberg, which flagged iRhythm's Zio Patch as a concrete AI monetization story in medtech. This isn't vaporware — it's FDA-cleared, recurring-revenue cardiac monitoring with a defensible niche. Medtech has been in the penalty box due to sector rotation into biopharma, which means iRhythm is on sale while the thesis is intact. A re-rating is one analyst upgrade away.

$WDC (Western Digital) — Morgan Stanley reiterated overweight with a $650 price target, up ~280% year-to-date. The storage cycle is back, AI infrastructure is eating drives for breakfast, and the Street is finally catching on. Still mid-cap enough to have room to run without being a mega-cap crowded trade.

$DXCM (Dexcom) — Bloomberg's healthcare conference coverage specifically called out Dexcom's AI carb-counting photo feature as a genuinely monetizable product. In a world where everyone's slapping AI on a press release, Dexcom is actually shipping features patients use daily. The diabetes management market is enormous and sticky — and DXCM is still trading below its 52-week high. Sometimes the boring healthcare stock is the sneaky winner.

The loudest trades aren't always the best ones. Sometimes the gem is just the stock nobody bothered to look at.